Director/PDMR Shareholding
Eco Animal Health Group Plc
04 April 2018
ECO Animal Health Group plc ("ECO" or the "Company")
Director/PDMR Shareholding and Notification
1. | Â | Details of the person discharging managerial responsibilities / person closely associated | |||
a. | Name | Â | Marc Loomes | ||
2. | Reason for the notification | ||||
a. | Position/status | CEO | |||
b. |
Initial notification
/Amendment |
Initial notification | |||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a. | Name | ECO Animal Health Group plc | |||
b. | LEI | 01818170 | |||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a. |
Description of the
Financial instrument, type of instrument Identification code |
Ordinary shares of 5p each in the capital of the Company (
“Ordinary
Sharesâ€
)
  ISIN: GB0032036807 LEI: 2138009XN9DJ3YP7OB55 |
|||
b. | Nature of the transaction |
Exercise of 100,000 options over Ordinary Shares with an exercise
price of £2.005
 Sale of 100,000 Ordinary Shares at a price of £5.28 |
|||
c. | Price(s) and volume(s) |
             Price(s)       Volume(s)  Exercise   £2.005         100,000  Sale        £5.28          100,000  |
|||
d. |
Aggregated information
· Aggregated volume · Price |
As above |
|||
e. | Date of the transaction | 2018/04/04 | |||
f. | Place of the transaction | London Stock Exchange (XLON) AIM market |
1. | Â | Details of the person discharging managerial responsibilities / person closely associated | |||
a. | Name | Â | Kevin Stockdale | ||
2. | Reason for the notification | ||||
a. | Position/status | Finance Director | |||
b. |
Initial notification
/Amendment |
Initial notification | |||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a. | Name | ECO Animal Health Group plc | |||
b. | LEI | 01818170 | |||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a. |
Description of the
Financial instrument, type of instrument Identification code |
Ordinary shares of 5p each in the capital of the Company (
“Ordinary
Sharesâ€
)
  ISIN: GB0032036807 LEI: 2138009XN9DJ3YP7OB55 |
|||
b. | Nature of the transaction |
Exercise of 40,000 options over Ordinary Shares with an exercise
price of £2.005
 Sale of 40,000 Ordinary Shares at a price of £5.28 |
|||
c. | Price(s) and volume(s) |
             Price(s)      Volume(s)  Exercise    £2.005        40,000  Sale       £5.28          40,000  |
|||
d. |
Aggregated information
· Aggregated volume · Price |
As above |
|||
e. | Date of the transaction | 2018/04/04 | |||
f. | Place of the transaction | London Stock Exchange (XLON) AIM market |
1. | Â | Details of the person discharging managerial responsibilities / person closely associated | |||
a. | Name | Â | Andrew Buglass | ||
2. | Reason for the notification | ||||
a. | Position/status | PDMR | |||
b. |
Initial notification
/Amendment |
Initial notification | |||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a. | Name | ECO Animal Health Group plc | |||
b. | LEI | 01818170 | |||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a. |
Description of the
Financial instrument, type of instrument Identification code |
Ordinary shares of 5p each in the capital of the Company (
“Ordinary
Sharesâ€
)
  ISIN: GB0032036807 LEI: 2138009XN9DJ3YP7OB55 |
|||
b. | Nature of the transaction |
Exercise of 250,000 options over Ordinary Shares with an exercise
price of £2.005
 Sale of 250,000 Ordinary Shares at a price of £5.28 |
|||
c. | Price(s) and volume(s) |
              Price(s)      Volume(s)  Exercise     £2.005       25,000  Sale         £5.28        25,000  |
|||
d. |
Aggregated information
· Aggregated volume · Price |
As above |
|||
e. | Date of the transaction | 2018/04/04 | |||
f. | Place of the transaction | London Stock Exchange (XLON) AIM market |
1. | Â | Details of the person discharging managerial responsibilities / person closely associated | |||
a. | Name | Â | Marc Coulier | ||
2. | Reason for the notification | ||||
a. | Position/status | PDMR | |||
b. |
Initial notification
/Amendment |
Initial notification | |||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a. | Name | ECO Animal Health Group plc | |||
b. | LEI | 01818170 | |||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a. |
Description of the
Financial instrument, type of instrument Identification code |
Ordinary shares of 5p each in the capital of the Company (
“Ordinary
Sharesâ€
)
  ISIN: GB0032036807 LEI: 2138009XN9DJ3YP7OB55 |
|||
b. |
Nature of the transaction |
Exercise of 20,000 options over Ordinary Shares with an exercise
price of £2.005
 Sale of 20,000 Ordinary Shares at a price of £5.28 |
|||
c. | Price(s) and volume(s) |
            Price(s)      Volume(s)  Exercise   £2.005      20,000  Sale      £5.28       20,000  |
|||
d. |
Aggregated information
· Aggregated volume · Price |
As above |
|||
e. | Date of the transaction | 2018/04/04 | |||
f. | Place of the transaction | London Stock Exchange (XLON) AIM market |
Enquiries
ECO Animal Health Group plc
Marc Loomes, CEO 020 8447 8899
Peter Lawrence, Non -Executive Chairman 020 8336 6190
Spiro Financial
Anthony Spiro 020 8336 6196
N+1 Singer ( Nominated Adviser)
Mark Taylor, James White, Brough Ransom 020 7496 3000
Peel Hunt LLP (Joint Broker)
James Steel, Dr Christopher Golden 020 7418 8900
View source version on businesswire.com: https://www.businesswire.com/news/home/20180405005488/en/